debrisoquin has been researched along with Weight Reduction in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coxon, GD | 1 |
| Furman, BL | 1 |
| Harvey, AL | 1 |
| McTavish, J | 1 |
| Mooney, MH | 1 |
| Arastoo, M | 1 |
| Kennedy, AR | 1 |
| Tettey, JM | 1 |
| Waigh, RD | 1 |
1 other study available for debrisoquin and Weight Reduction
| Article | Year |
|---|---|
Benzylguanidines and other galegine analogues inducing weight loss in mice.
Topics: Animals; Anti-Obesity Agents; Benzyl Compounds; Dietary Fats; Guanidines; Male; Mice; Mice, Inbred B | 2009 |